Apr. 30, 2014—A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
May. 22, 2012—Patients and their families will have a more active role and voice in research designed to improve the quality and safety of patient care, thanks to a federal grant received by Vanderbilt University Medical Center researchers.